Benoxaprofen: effect on cutaneous lesions in psoriasis.

British medical journal (Clinical research ed.) ·Vol. 285 ·No. 6350 ·1982-10-30 ·Pages 1241

Allen BR, Littlewood SM

Abstract

暂无摘要

MeSH Terms

Adult Aged Dermatologic Agents/therapeutic use Female Humans Male Middle Aged Propionates/therapeutic use Psoriasis/drug therapy

Chemicals

Dermatologic Agents Propionates benoxaprofen

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Allen B R

Littlewood S M

References (5)

5 references, click to expand

The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis.
J Pharm Pharmacol. 1977 Jun;29(6):330-6 PMID: 18568
Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue.
Arch Dermatol. 1979 Oct;115(10):1183-4 PMID: 507858
Inhibition of rabbit PMN lipoxygenase activity by benoxaprofen.
J Pharm Pharmacol. 1979 Nov;31(11):778-80 PMID: 41912
Leukotriene B4 and neutrophil function: a review.
J R Soc Med. 1981 Nov;74(11):831-3 PMID: 6271967
Side effects of benoxaprofen.
Br Med J (Clin Res Ed). 1982 May 8;284(6326):1368-9 PMID: 6803979

Article Info

Journal

British medical journal (Clinical research ed.)

Abbr.

Br Med J (Clin Res Ed)

ISSN

0267-0623

DOI

Published

1982-10-30

Pages

1241

Language

English

Region

England

NLM ID

8302911

PMCID

PMC1499777

Subset

External Links

Analysis Services